Structure based drug designing of a novel anti-flaviviral inhibitor for nonstructural 3 Protein

  • Jitendra S
  • Vinay R
N/ACitations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

UNLABELLED Literature shows that Flaviviruses cause a variety of diseases, including fevers, encephalitis, and hemorrhagic fevers. NS3 is a multifunctional protein with an Nterminal protease domain (NS3pro) that is responsible for proteolytic processing of the viral polyprotein, and a C-terminal region that contains an RNA triphosphatase, RNA helicase and RNA-stimulated NTPase domain that are essential for RNA replication. Therefore, NS3 protein is the preferential choice for inhibition to stop the proteolytic processing. Hence, the 3D structure of NS3 protein was modeled using homology modeling by MODELLER 9v7. Evaluation of the constructed NS3 protein models were done by PROCHECK, VERYFY3D and through ProSA calculations. Ligands for the catalytic triad were designed using LIGBUILDER. The NS3 protein's catalytic triad was explored to find out the critical interactions pattern for inhibitor binding using molecular docking methodology using AUTODOCK Vina. It should be noted that these predicted data should be validated using suitable assays for further consideration. ABBREVIATIONS DOPE - Discrete optimized protein energy, WHO - World Health Organization, ADME/T - Absorption, Distribution, Metabolism, Excretion and Toxicity.

Cite

CITATION STYLE

APA

Jitendra, S., & Vinay, R. (2011). Structure based drug designing of a novel anti-flaviviral inhibitor for nonstructural 3 Protein. Bioinformation, 6(2), 57–60. https://doi.org/10.6026/97320630006057

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free